New Drug Application News
Most Popular New Drug Application Story
FDA rejects SkyePharma's NDA for Flutiform
The U.K.'s SkyePharma says the FDA has officially rebuffed its NDA for the asthma drug Flutiform, its lead drug prospect, spelling out "substantive" issues that need to be resolved ahead of an Read more...
Latest Headlines
- October 13, 2011
- February 22, 2011
- January 21, 2010
- January 13, 2010
- December 10, 2009
- November 19, 2009
- September 10, 2009
- April 23, 2009
- December 24, 2008
- November 15, 2007
- November 9, 2007
- October 24, 2007
- September 20, 2007
- August 8, 2007
- July 17, 2007
- July 16, 2007
- June 27, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
